Cargando…
A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia
Background: Schizophrenia is a severe and complex disease with substantial economic and social burdens. Despite multiple treatment choices, adverse events, and impaired social functions are still challenges in clinical therapy. Pharmacoeconomic evaluations could provide evidence to help decision mak...
Autores principales: | Wang, Luying, Shi, Fenghao, Guan, Xin, Xu, He, Liu, Jing, Li, Hongchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564012/ https://www.ncbi.nlm.nih.gov/pubmed/34746073 http://dx.doi.org/10.3389/fpubh.2021.689123 |
Ejemplares similares
-
Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
por: Chen, Pingyu, et al.
Publicado: (2022) -
Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review
por: Zhou, Ting, et al.
Publicado: (2021) -
Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
por: Wang, Yingcheng, et al.
Publicado: (2021) -
Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
por: Liu, Xinyi, et al.
Publicado: (2023) -
Economic Burden of Myocardial Infarction Combined With Dyslipidemia
por: Chen, Pingyu, et al.
Publicado: (2021)